Mutational screening of the CYP26A1 gene in patients with caudal regression syndrome

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 2, 2006, Pages 86-95

  De Marco, Patrizia ^a   Merello, Elisa ^a   Mascelli, Samantha ^a   Raso, Alessandro ^a   Santamaria, Andrea ^a   Ottaviano, Catherine ^a   Calevo, Maria Grazia ^a   Cama, Armando ^a   Capra, Valeria ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Caudal regression syndrome (CRS); CYP26A1; Denaturing high performance liquid chromatography (DHPLC); Retinoic acid (RA); Single nucleotide polymorphism (SNP)

Indexed keywords

CYTOCHROME P450 26A1; RETINOIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANUS ATRESIA; ARTICLE; CAUDAL REGRESSION SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYP26A1 GENE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC TRANSFECTION; HAPLOTYPE; HUMAN; INTRON; LUMBOSACRAL SPINE; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPINA BIFIDA;

CYTOCHROME P-450 ENZYME SYSTEM; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPINAL CORD; SPINAL CORD DISEASES;

ANIMALIA;

EID: 33644870083     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20225     Document Type: Article

References (39)

1. Abbott BD, Ebron-McCoy M, Andrews JE. 1995. Cell death in rat and mouse embryos exposed to methanol in whole embryo culture. Toxicology 97:159-171.
2. Abu-Abed S, Dollè P, Metzger D, et al. 2001. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 15:226-240.
3. Agundez JA, Ledesma MC, Benitez J, et al. 1995. CYP2D6 gene and risk of liver cancer. Lancet 345:830-831.
4. Antonarakis SE. 1998. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11:1-3.
5. Blencowe BJ. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 25:106-110.
6. Caceres JF, Krainer AR. 1997. Mammalian pre-mRNA splicing factors. In: Krainer AR, editor. Eukaryotic mRNA processing. Oxford: IRL Press. p 174-212.
7. Cama A, Palmieri A, Capra V, et al. 1996. Multidisciplinary management of caudal regression syndrome (26 cases). Eur J Pediatr Surg 6:44-45.
8. Chambon PA. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
9. Chenoweth CK, Kellogg SJ, Abu-Yousef MM. 1991. Antenal sonographic diagnosis of sirenomielia. J Clin Ultrasound 19:167-171.
10. Dias MS, Walker ML. 1992. The embryogenesis of complex dysraphic malformations: a disorder of gastrulation? Pediatr Neurosurg 18:229-253.
11. Duester G. 2000. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 267:4315-4324.
12. Duhamel B. 1961. From the mermaid to anal imperforation: the syndrome of caudal regression. Arch Dis Child 36:152-155.
13. Fujii H. 1997. Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J 16:4163-4173.
14. Fullana A, Garcia-Frias E, Martinez-Frias ML, et al. 1986. Caudal deficiency and asplenia anomalies in sibs. Am J Med Genet Suppl 2:23-29.
15. Hofmann C, Eichele G. 1994. Retinoids in development. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids: biology, chemistry, and medicine. New York: Raven Press. p 387-441.
16. Johansson I, Lundqvist E, Bertilsson L, et al. 1993. Inherited amplification of an active gene in the cytochrome P450 CYP 2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 90:11825-11829.
17. Lewontin RC. 1964. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49:49-67.
18. Liu HX, Zhang M, Krainer AR. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev 12:1998-2012.
19. Liu HX, Cartegni L, Zhang MQ, Krainer AR. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58.
20. MacLean G, Abu-Abed S, Dollé P, et al. 2001. Cloning of a novel retinoic acid-metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev 107:195-201.
21. Padmanabhan R. 1998. Retinoic acid-induced asymmetric craniofacial growth and cleft palate in the TO mouse fetus. Reprod Toxicol 11:843-860.
22. Pang D. 1993. Sacral agenesis and caudal spinal cord malformations. Neurosurgery 92:755-779.
23. Passarge E, Lenz W. 1966. Syndrome of caudal regression in infants of diabetic mothers: observations of further cases. Pediatrics 37:672-675.
24. Renshaw TS. 1978. Sacral agenesis: a classification and review of twenty-three cases. J Bone Joint Surg Am 60:373-383.
25. Richard I, Beckmann JS. 1995. How neutral are synonymous codon mutations? Nat Genet 10:259.
26. Ross SA, McCaffery PJ, Drager UC, De Luca LM. 2000. Retinoids in embryonal development. Physiol Rev 80:1021-1054.
27. Sachse C, Brockmoller J, Bauer S, Roots I. 1997. Cytochrome P450 2D6 variants in a Caucasian population: allelic frequency and phenotypic consequences. Am J Hum Genet 60:284-295.
28. Sakai Y, Meno C, Fujii H, et al. 2000. The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterior-posterior axis within the mouse embryo. Genes Dev 15:213-225.
29. Schaal TD, Maniatis T. 1999. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol Cell Biol 19:1705-1719.
30. Sonnoveld E, van den Brink CE, van der Leede BM, et al. 1998. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Differ 9:629-637.
31. Taimi M, Helvig C, Wisniewski J, et al. 2004. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 279:77-85.
32. Tortori-Donati P, Fondelli MP, Rossi A, et al. 1999. Segmental spinal dysgenesis: neurological findings with clinical and embryologic correlation. Am J Neuroradiol 20:445-446.
33. Tortori-Donati P, Rossi A, Biancheri R, Cama A. 2005. Congenital malformation of the spine and the spinal cord. In: Tortori-Donati P, editor. Pediatric neuroradiology head, neck and spine. New York: Springer. p 1551-1608.
34. Trofimova-Griffin ME, Juchau MR. 1998. Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues. Biochem Biophys Res Commun 252:487-491.
35. Twickler D, Budorick N, Pretorius D, et al. 1993. Caudal regression versus sirenomielia: sonographic clues. J Ultrasound Med 12:323-330.
36. Watakabe A, Tanaka K, Shimura Y. 1993. The role of exon sequences in splice site selection. Genes Dev 7:407-418.
37. White JA, Beekett-Jones B, Guo YD, et al. 1997. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 272:18538-18541.
38. White JA, Ramshaw H, Taimi M, et al. 2000. Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci USA 97:6403-6648.
39. Xiao W, Oefner PJ. 2001. Denaturing high-performance liquid chromatography: A review. Hum Mutat 17(6):439-474.